Phastar and Beaconcure Announce Partnership to Deliver Process Revolution in Clinical Data Review
20 Mayo 2024 - 6:00AM
Business Wire
Beaconcure Inc., a leader in AI-enabled clinical data validation
and automation, announces a strategic partnership with Phastar
Inc., a global specialist biometrics contract research organization
(CRO), to enhance clinical review processes in clinical trials.
This partnership combines Beaconcure's advanced technology with
Phastar’s extensive experience and vision in the clinical data
analytics domain, to streamline clinical trial development and
accelerate the delivery of lifesaving drugs.
Ilan Carmeli, Chief Operating Officer and Co-founder at
Beaconcure, expressed his enthusiasm about the partnership,
stating, "We are thrilled to collaborate with Phastar, a leader in
clinical trial analytics. By leveraging Verify, Phastar is now
equipped with a collaboration platform that reduces the potential
for human error and increases efficiency and transparency, enabling
faster study validation and approvals. By utilizing a unified
platform, teams can integrate efforts, improve data integrity, and
accelerate decision-making. These enhancements enable Phastar to
manage internal communications and sponsor interactions more
effectively, transforming clinical reviews, shortening review
cycles, and expediting the delivery of treatments."
Ping-Chung Chang, Head of Business Transformation and China
General Manager at Phastar, highlighted the importance of the
partnership: "We at Phastar prioritize our customers' needs and
continuously seek innovative solutions to ensure timely access to
lifesaving treatments for patients with urgent needs. Integrating
Beaconcure’s Verify platform into our processes is an impactful
step and will help unlock further innovations across clinical data
reporting, reviewing, and submission stages. We will utilize Verify
to address critical areas in clinical review with automatically
generated audit trails, streamlined data reporting delivery, and
optimized workflow management.”
Beaconcure is committed to continuous innovation and being at
the forefront of developing technological advancements that
transform clinical research. “Through this partnership, Beaconcure
and Phastar are actively engaged in exploring new standards in the
industry to increase speed and compliance in clinical trials,” says
Christine Oliver, Chief Executive Officer at Beaconcure. “By
partnering with Phastar and drawing on Mr. Chang’s expertise, we’re
not just deploying solutions—we’re creating a dynamic system that
learns and improves over time.”
About Phastar Phastar is an award-winning, global,
specialist biometrics contract research organization, offering
leading data management, biostatistics, data science, statistical
consulting, clinical trial reporting, and data analytics technology
services. Phastar provides expert consultants, manages and delivers
project-based and FSP arrangements, and fosters preferred
partnerships. With 15 offices worldwide, Phastar’s number one
priority is ensuring on-time, quality work and assisting customers
in optimizing clinical research.
About Beaconcure Beaconcure supports biopharmaceutical
companies and CROs with Verify, a secure online workspace for
AI-enabled clinical study analysis validation. Designed in
partnership with trusted large pharmaceutical companies and used in
an increasing number of approved products, Verify streamlines
validation workflows, reduces error rates, and increases efficiency
compared to traditional processes. For more information, visit
www.beaconcure.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240520818825/en/
For media inquiries: Sean Wall Senior Vice President Commercial
at Beaconcure sean@beaconcure.com